Femtech In Canada: A Practical Guide To Patents, Trademarks And IP Strategy

Femtech, defined as technology and innovation focused on women's health, has rapidly evolved from a niche sector into a cornerstone of the modern healthcare economy. The industry addresses critical gaps in care for menstrual health, fertility, pregnancy, menopause, and chronic conditions disproportionately affecting women.

According to the McKinsey Health Institute¹, closing the women's health gap and scaling women's health technologies could unlock roughly USD 1 trillion in additional global GDP annually by 2040 and add about USD 27 billion to Canada's GDP², underscoring the significant economic gains at stake.

This rapidly expanding market makes strategic intellectual property protection essential for innovators in the Femtech space. Effective IP strategies for Femtech begin by securing the core technology with patents and the consumer trust with trademarks, creating defensible moats that help founders safeguard breakthrough technologies, attract investment, and ensure sustainable commercial success in the face of unique subject matter eligibility challenges characteristic of women's health technologies.

Patents: Key considerations for Canadian Femtech companies

Patents safeguard technological innovations by granting time-limited exclusivity over new, useful, and non-obvious inventions. For Femtech ventures, this can encompass device architectures, sensor assemblies, signal processing pipelines, diagnostic methods, therapeutic delivery mechanisms, formulations, and computer-implemented inventions that produce a concrete technical effect.

Canada provides a limited grace period for an applicant's own disclosures made within the year preceding the Canadian filing date, but public disclosure before filing can forfeit rights in many foreign jurisdictions. As a result, founders should prioritize pre-filing confidentiality and coordinate publication, marketing, and clinical study timelines with patent counsel.

For medical and health technologies, claim‑drafting nuances matter; and the law is evolving. In Canada, the Supreme Court of Canada is currently considering the patent eligibility issue of methods of medical treatment³, until its decision issues, such methods remain generally unpatentable.

However, devices for medical treatment, diagnostic methods, and "uses" of a device or drug for medical treatment are patent‑eligible. Careful claim strategy—focusing on patent-eligible subject matter such as devices, systems, and certain "use" claims, and avoiding active medical or surgical steps or elements that require a clinician's skill and judgment—can help mitigate risk.

By contrast, the United States permits methods of medical treatment, though diagnostic method claims can face eligibility scrutiny. For global portfolios, it is essential to coordinate filing and claim strategies early so claims can be tailored to local eligibility doctrines and to optimize protection in each jurisdiction.

For computer‑implemented inventions—particularly AI/ML‑enabled analytics common in Femtech— eligibility challenges can arise as the Patent Office applies a "physicality" requirement to prevent claims from merely reciting an abstract algorithm or data analysis. One can satisfy this requirement by anchoring the invention to specific physical hardware components (such as integrated sensors) and/or demonstrating improvements in computer functioning, and by framing the invention as a tangible, practical application with real‑world technical and commercial value.

While datasets themselves are not patentable, inventions that transform, process, or use data to produce a technical effect can be. Early engagement with experienced patent counsel helps position claims to satisfy eligibility and support enforceability.

Procedurally, examination must be requested within prescribed time limits, and acceleration mechanisms may be available, including programs that leverage favorable outcomes in partner jurisdictions. A well-managed prosecution strategy can reduce pendency, preserve broad claim scope, and align issuance with commercialization milestones.

Patents: Best practices for Femtech founders

• Structure invention capture: Implement an internal process to log prototypes, test plans, data, and iteration histories, making it easier to prioritize filings around features that move clinical or user adoption metrics, and maintain NDAs with collaborators and vendors.
• Anchor claims to measurable advantages: In data-heavy products, articulate how the system achieves superior computer functionality or practical application, such as latency, battery life, or privacy guarantees, and ensure that the specification provides technical support for those advantages.
• Use a layered strategy: Combine utility patents for core functionality with industrial design protection for product appearance and, where relevant, trade secrets for models, training data curation, or deployment playbooks that are difficult to reverse engineer.
• Plan globally with discipline: Employ international mechanisms to keep options open while deferring costs, and choose target jurisdictions based on manufacturing hubs, key markets, and competitor footprints. Coordinate with foreign counsel on local nuances for medical related claims and software eligibility.
• Separate patentability from freedom to operate: A patent on your invention does not guarantee that commercialization is non-infringing. Conduct targeted freedom-to-operate analyses to identify and mitigate risks from third-party rights.

Trademarks: Why trademarks matter in Femtech

In a field as intimate and trust-dependent as Femtech, branding is not just about visibility—it's about credibility. Consumers want to feel secure using apps, devices, and platforms that handle sensitive health data. Trademarks, which protect names, logos, slogans, and other brand identifiers, serve as a guarantee of origin and quality.

A trademark registered with the Canadian Intellectual Property Office (CIPO) grants exclusive rights to use the mark across Canada in connection with defined goods or services. This legal recognition helps Femtech founders prevent competitors from adopting confusingly similar branding, thereby reducing the risk of reputational damage or customer confusion.

For example, Elvie, though based in the UK, has filed for protection in Canada due to its pelvic health devices being distributed here. Canadian firms must be just as proactive in protecting their marks abroad.

Trademarks: Strategic advantages for Canadian Femtech startups

1. Market differentiation and brand equity

With more Femtech startups entering the Canadian and global markets, a well-defined and protected brand becomes a key differentiator.

Take Ova Health, a London-based startup which is developing smart sensors to deliver real-time hormonal insights for menopause health. It is developing a brand strategy to position itself so that it can safely promote its brand within Canada and abroad. Trademark protection ensures that its brand identity remains exclusive and enforceable.

2. Investor and partner confidence

Early-stage Femtech ventures often rely on venture capital and strategic partnerships. A registered trademark adds value to a company's portfolio by demonstrating that its brand assets are protected and enforceable.

3. Legal recourse and enforcement

Trademark registration provides access to powerful enforcement mechanisms. For Canadian Femtech brands with e-commerce operations—especially those selling products via platforms like Amazon or advertising on Instagram—a registered mark facilitates takedown requests and digital rights enforcement.

Moreover, if a competitor in Canada were to use a similar name, logo, or slogan, the owner of a registered trademark could initiate action under the Trademarks Act, seeking remedies such as injunctions, damages, or an accounting of profits.

Trademarks: Best practices for Femtech founders

Register early: Canadian law allows for the filing of trademarks based on "proposed use." Don't wait for your product to hit the market—secure your mark as part of your launch strategy.

Do the due diligence: Conduct comprehensive clearance searches, ideally with professional legal assistance, to avoid conflicts and potential litigation.

Plan for global expansion: Consider future markets. Through the Madrid Protocol, Canadian businesses can apply for international trademark protection using a single, streamlined process.

Conclusion

Canada's Femtech sector is gaining momentum, driven by startups that are innovating with purpose and social impact. A holistic IP strategy—anchored by both patents and trademarks—is a practical cornerstone of that effort.

By filing patents early, drafting claims that survive eligibility scrutiny, and integrating prosecution with commercialization, founders can secure durable advantages that compound over time, yielding defensible differentiation, stronger investor readiness, and more productive partnerships.

In parallel, trademark protection is essential to transform inventive ideas into lasting brands: it builds trust with users, attracts investment, and helps fend off infringement as companies scale. Together, patents that protect core technology and registered trademarks that safeguard brand identity provide a clear path to global growth for any Canadian Femtech entrepreneur aiming to lead in this transformative space.

Footnotes

1. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies

2. https://femtech.ca/canadas-37-billion-opportunity-why-closing-the-womens-health-gap-is-our-smartest-investment/

3. On October 9, 2025, the Supreme Court heard oral arguments in Pharmascience Inc v Janssen Inc (Supreme Court File No 41209) and reserved its decision to a later date.